Interpace Biosciences Inc organizacji Forward P/E

Jaka jest wartość Forward P/E organizacji Interpace Biosciences Inc?

Wartość Forward P/E organizacji Interpace Biosciences Inc to -0.76

Jaka jest definicja Forward P/E?



Wskaźnik ceny do zysku to stosunek ceny akcji spółki do szacunkowego zysku spółki na akcję za następne dwanaście miesięcy.

The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.

Forward P/E firm w Health Care sektor na NASDAQ w porównaniu do Interpace Biosciences Inc

Czym się zajmuję organizacja Interpace Biosciences Inc?

advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Firmy z forward p/e podobne do Interpace Biosciences Inc